{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"6 2","pages":"Pages 110-113"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147361348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"6 2","pages":"Pages 90-109"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147361352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"6 2","pages":"Pages 136-138"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147361355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.08.003
C. Cassius , C. Hua , J. Krygier , M. Lehericey , A. Nouchi , R. Blaizot , A. Bertolotti , pour le GrIDIST
{"title":"Les analyses bibliographiques en maladies infectieuses du groupe GrIDIST – sélection 3e trimestre 2025","authors":"C. Cassius , C. Hua , J. Krygier , M. Lehericey , A. Nouchi , R. Blaizot , A. Bertolotti , pour le GrIDIST","doi":"10.1016/j.fander.2025.08.003","DOIUrl":"10.1016/j.fander.2025.08.003","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 555-559"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.10.020
D. Penso-Assathiany , E. Démoulins , M. Moyal-Barracco
{"title":"La photographie, le crayon ou la puce ?","authors":"D. Penso-Assathiany , E. Démoulins , M. Moyal-Barracco","doi":"10.1016/j.fander.2025.10.020","DOIUrl":"10.1016/j.fander.2025.10.020","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 483-484"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.10.021
D. Penso-Assathiany , B. Crickx
{"title":"Hommage à François Prigent","authors":"D. Penso-Assathiany , B. Crickx","doi":"10.1016/j.fander.2025.10.021","DOIUrl":"10.1016/j.fander.2025.10.021","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 553-554"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.06.004
S. Ingen-Housz-Oro , F. Amatore , R. André , M. de Vicq de Cumptich , R. Janela-Lapert , C. Ram-Wolff , M. Beylot-Barry
{"title":"Mycosis fongoïde au stade limité","authors":"S. Ingen-Housz-Oro , F. Amatore , R. André , M. de Vicq de Cumptich , R. Janela-Lapert , C. Ram-Wolff , M. Beylot-Barry","doi":"10.1016/j.fander.2025.06.004","DOIUrl":"10.1016/j.fander.2025.06.004","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 547-549"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.09.003
N. Sigg , S. Leducq , S. Barbarot , D. Staumont , C. Ertus , C. Hurson , N. Lachaume , D. Lannoy , B. Mille , F. Payot , D. Penso-Assathiany , E. Proux , V. Reynaud , P. Zukervar , A. Foureau , B. Guillot , O. Chosidow , M.-S. Doutre
<div><div>La dermatite atopique est une maladie inflammatoire chronique fréquente qui touche 10 à 20 % des enfants en Europe mais également les adultes (4 à 5 % en France). Au cours de ces dernières années, la prise en charge des formes modérées à sévères a été modifiée par l’arrivée de nouveaux traitements. Le Centre de preuves en dermatologie et le Groupe de recherche sur l’eczéma atopique de la Société française de dermatologie ont élaboré, selon la méthode ADAPTE, des recommandations pour la prise en charge de la dermatite atopique. Celles-ci s’appuient sur les recommandations européennes publiées en 2022 par l’European Dermatology Forum. Cinq grands axes sont abordés : la prise en charge globale du patient (impact de la maladie sur la vie quotidienne, familiale et professionnelle, besoins thérapeutiques, comorbidités, éducation thérapeutique, gestion de la corticophobie), les facteurs environnementaux (rôle dans l’exacerbation de la maladie, intérêt des mesures d’éviction), les traitements topiques (modalités de prescription, gestion du prurit et des complications infectieuses en particulier bactériennes et virales), les traitements systémiques (critères de prescription, place des traitements conventionnels, des biothérapies, des inhibiteurs de Janus Kinase, de la photothérapie et des thérapeutiques alternatives), les situations particulières (prise en charge de l’enfant, l’adolescent, la femme enceinte et allaitante, l’adulte souhaitant concevoir et la personne âgée). L’objectif de ces recommandations est d’actualiser les recommandations européennes et d’aborder d’autres questions d’intérêt afin de favoriser une prise en charge optimale harmonisée des patients atteints de dermatite atopique en France.</div></div><div><div>Atopic dermatitis is a common chronic inflammatory disease affecting 10 to 20% of children throughout Europe and 4 to 5% of adults in France. In recent years, the management of moderate to severe forms has evolved with the introduction of new treatments. The Dermatology Evidence Center and the Atopic Eczema Research Group of the French Society of Dermatology have developed guidelines for the management of atopic dermatitis using the ADAPTE methodology. These guidelines are based on the recommendations published in 2022 by the European Dermatology Forum. Five key areas are addressed: comprehensive patient management (impact of the disease on daily, family, and professional life, therapeutic needs, comorbidities, therapeutic education, management of topical corticosteroid phobia), environmental factors (role in disease exacerbation, relevance of avoidance measures), topical treatments (prescription modalities, management of pruritus and infectious complications, particularly bacterial and viral), systemic treatments (prescription criteria, role of conventional treatments, biologics, Janus Kinase inhibitors, phototherapy, and alternative therapies), and special situations (management of children, adolescents, pregnant and bre
特应性皮炎是一种常见的慢性炎症性疾病，在欧洲影响10 - 20%的儿童，但在法国也影响4 - 5%的成年人。近年来，随着新疗法的出现，对中度至重度患者的治疗已经发生了变化。皮肤病证据中心和法国皮肤病学会特应性湿疹研究小组使用ADAPTE方法开发了特应性皮炎的治疗建议。这些建议是基于欧洲皮肤病学论坛（European Dermatology Forum）于2022年发布的欧洲建议。讨论了五个主要领域：全面接管病人的疾病(影响日常生活、家庭和工作,需要治疗并发症、治疗、教育、管理corticophobie)、环境因素(加剧疾病中的作用,驱逐措施的兴趣),外用治疗(瘙痒和时效,管理细则,细菌和病毒感染性并发症尤其是),全身治疗（处方标准、常规治疗的位置、生物治疗、Janus Kinase抑制剂、光疗和替代治疗）、特殊情况（儿童、青少年、孕妇和哺乳期妇女、希望怀孕的成年人和老年人的护理）。这些建议的目的是更新欧洲的建议，并解决其他感兴趣的问题，以促进法国特应性皮炎患者的最佳协调护理。特应性皮炎是一种常见的慢性炎症性疾病，影响欧洲10 - 20%的儿童和法国4 - 5%的成年人。近年来，随着新疗法的引入，中度至重度形式的管理有所发展。皮肤病证据中心和法国皮肤病学会特应性湿疹研究小组已经制定了使用ADAPTE方法管理特应性皮炎的指南。这些指南基于欧洲皮肤病论坛于2022年发布的建议。解决了五个关键领域：病人综合管理类(impact of the disease据daily、家庭和职业生活、治疗机构needs comorbidities治疗机构、教育、management of topical corticosteroid phobia)、环境因素(in相关性疾病的加剧,of地面的措施)的作用,topical时效与对照(management of pruritus并发症,促进改革,需认真体细菌和病毒)、系统与常规的作用(时效标准,与对照,生物学、Janus激酶抑制剂、光疗和替代疗法)和特殊情况（儿童、青少年、孕妇和哺乳期妇女、希望怀孕的成年人和老年人的管理）。本指南的目的是更新欧洲的建议，并解决其他相关问题，以促进在法国的特应性皮炎患者的最佳和协调管理。
{"title":"Recommandations françaises pour la prise en charge de la dermatite atopique","authors":"N. Sigg , S. Leducq , S. Barbarot , D. Staumont , C. Ertus , C. Hurson , N. Lachaume , D. Lannoy , B. Mille , F. Payot , D. Penso-Assathiany , E. Proux , V. Reynaud , P. Zukervar , A. Foureau , B. Guillot , O. Chosidow , M.-S. Doutre","doi":"10.1016/j.fander.2025.09.003","DOIUrl":"10.1016/j.fander.2025.09.003","url":null,"abstract":"<div><div>La dermatite atopique est une maladie inflammatoire chronique fréquente qui touche 10 à 20 % des enfants en Europe mais également les adultes (4 à 5 % en France). Au cours de ces dernières années, la prise en charge des formes modérées à sévères a été modifiée par l’arrivée de nouveaux traitements. Le Centre de preuves en dermatologie et le Groupe de recherche sur l’eczéma atopique de la Société française de dermatologie ont élaboré, selon la méthode ADAPTE, des recommandations pour la prise en charge de la dermatite atopique. Celles-ci s’appuient sur les recommandations européennes publiées en 2022 par l’European Dermatology Forum. Cinq grands axes sont abordés : la prise en charge globale du patient (impact de la maladie sur la vie quotidienne, familiale et professionnelle, besoins thérapeutiques, comorbidités, éducation thérapeutique, gestion de la corticophobie), les facteurs environnementaux (rôle dans l’exacerbation de la maladie, intérêt des mesures d’éviction), les traitements topiques (modalités de prescription, gestion du prurit et des complications infectieuses en particulier bactériennes et virales), les traitements systémiques (critères de prescription, place des traitements conventionnels, des biothérapies, des inhibiteurs de Janus Kinase, de la photothérapie et des thérapeutiques alternatives), les situations particulières (prise en charge de l’enfant, l’adolescent, la femme enceinte et allaitante, l’adulte souhaitant concevoir et la personne âgée). L’objectif de ces recommandations est d’actualiser les recommandations européennes et d’aborder d’autres questions d’intérêt afin de favoriser une prise en charge optimale harmonisée des patients atteints de dermatite atopique en France.</div></div><div><div>Atopic dermatitis is a common chronic inflammatory disease affecting 10 to 20% of children throughout Europe and 4 to 5% of adults in France. In recent years, the management of moderate to severe forms has evolved with the introduction of new treatments. The Dermatology Evidence Center and the Atopic Eczema Research Group of the French Society of Dermatology have developed guidelines for the management of atopic dermatitis using the ADAPTE methodology. These guidelines are based on the recommendations published in 2022 by the European Dermatology Forum. Five key areas are addressed: comprehensive patient management (impact of the disease on daily, family, and professional life, therapeutic needs, comorbidities, therapeutic education, management of topical corticosteroid phobia), environmental factors (role in disease exacerbation, relevance of avoidance measures), topical treatments (prescription modalities, management of pruritus and infectious complications, particularly bacterial and viral), systemic treatments (prescription criteria, role of conventional treatments, biologics, Janus Kinase inhibitors, phototherapy, and alternative therapies), and special situations (management of children, adolescents, pregnant and bre","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 493-533"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.fander.2025.03.015
N. Kluger
{"title":"Hématohidrose diagnostiquée comme des stigmates religieux : un « cold case » revisité","authors":"N. Kluger","doi":"10.1016/j.fander.2025.03.015","DOIUrl":"10.1016/j.fander.2025.03.015","url":null,"abstract":"","PeriodicalId":100088,"journal":{"name":"Annales de Dermatologie et de Vénéréologie - FMC","volume":"5 8","pages":"Pages 544-546"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145625318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：